Compare SPB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPB | LMAT |
|---|---|---|
| Founded | 1906 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 1994 | 2006 |
| Metric | SPB | LMAT |
|---|---|---|
| Price | $78.94 | $81.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $98.75 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 289.5K | 219.4K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.38% | 1.20% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 1.01 | ★ 1.42 |
| Revenue | ★ $3,802,100,000.00 | $249,602,000.00 |
| Revenue This Year | $1.92 | $10.79 |
| Revenue Next Year | $1.26 | $9.54 |
| P/E Ratio | $78.12 | ★ $58.63 |
| Revenue Growth | ★ 20.86 | 13.53 |
| 52 Week Low | $51.41 | $78.22 |
| 52 Week High | $99.06 | $118.01 |
| Indicator | SPB | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 49.76 |
| Support Level | $77.74 | $78.35 |
| Resistance Level | $80.83 | $83.15 |
| Average True Range (ATR) | 1.97 | 2.29 |
| MACD | 0.16 | 0.36 |
| Stochastic Oscillator | 45.02 | 48.66 |
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.